{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:55:20Z","timestamp":1791672920137,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11864-019-0626-5","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T09:00:36Z","timestamp":1553677236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Symptoms of and Palliative Treatment for Unresectable Skin Cancer"],"prefix":"10.1007","volume":"20","author":[{"given":"Hiroyuki","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"626_CR1","first-page":"120","volume":"810","author":"U Leiter","year":"2014","unstructured":"Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014;810:120\u201340.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"626_CR2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","volume":"166","author":"A Lomas","year":"2012","unstructured":"Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069\u201380. \n                      https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10830.x\n                      \n                    .","journal-title":"Br J Dermatol"},{"issue":"5","key":"626_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/cmr.0000000000000375","volume":"27","author":"T Tomizuka","year":"2017","unstructured":"Tomizuka T, Namikawa K, Higashi T. Characteristics of melanoma in Japan: a nationwide registry analysis 2011-2013. Melanoma Res. 2017;27(5):492\u20137. \n                      https:\/\/doi.org\/10.1097\/cmr.0000000000000375\n                      \n                    .","journal-title":"Melanoma Res"},{"issue":"6","key":"626_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/14737140.2018.1457955","volume":"18","author":"T Ito","year":"2018","unstructured":"Ito T, Kaku-Ito Y, Furue M. The diagnosis and management of extramammary Paget\u2019s disease. Expert Rev Anticancer Ther. 2018;18(6):543\u201353. \n                      https:\/\/doi.org\/10.1080\/14737140.2018.1457955\n                      \n                    .","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"626_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/1346-8138.13527","volume":"44","author":"H Goto","year":"2017","unstructured":"\u2022\u2022 Goto H, Yoshikawa S, Otsuka M, Omodaka T, Yoshimi K, Yoshida Y, et al. Symptom prevalence in patients with advanced skin cancer. J Dermatol. 2017;44(2):123\u20136. \n                      https:\/\/doi.org\/10.1111\/1346-8138.13527\n                      \n                     The first study on symptom prevalence in patients with unresectable skin cancer.","journal-title":"J Dermatol"},{"issue":"5","key":"626_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0885-3924(99)00096-2","volume":"18","author":"T Morita","year":"1999","unstructured":"Morita T, Tsunoda J, Inoue S, Chihara S. Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manag. 1999;18(5):338\u201346.","journal-title":"J Pain Symptom Manag"},{"issue":"9","key":"626_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3109\/07357907.2012.726387","volume":"30","author":"AK Salama","year":"2012","unstructured":"Salama AK, Rosa N, Scheri RP, Herndon JE, Tyler DS, Marcello J, et al. The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost. Cancer Investig. 2012;30(9):637\u201341. \n                      https:\/\/doi.org\/10.3109\/07357907.2012.726387\n                      \n                    .","journal-title":"Cancer Investig"},{"issue":"8","key":"626_CR8","first-page":"1995","volume":"34","author":"LH Einhorn","year":"1974","unstructured":"Einhorn LH, Burgess MA, Vallejos C, Bodey GP Sr, Gutterman J, Mavligit G, et al. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res. 1974;34(8):1995\u20132004.","journal-title":"Cancer Res"},{"issue":"7","key":"626_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/jso.23155","volume":"106","author":"ND Brougham","year":"2012","unstructured":"Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012;106(7):811\u20135. \n                      https:\/\/doi.org\/10.1002\/jso.23155\n                      \n                    .","journal-title":"J Surg Oncol"},{"issue":"2","key":"626_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ygyno.2013.02.029","volume":"129","author":"Y Cai","year":"2013","unstructured":"Cai Y, Sheng W, Xiang L, Wu X, Yang H. Primary extramammary Paget\u2019s disease of the vulva: the clinicopathological features and treatment outcomes in a series of 43 patients. Gynecol Oncol. 2013;129(2):412\u20136. \n                      https:\/\/doi.org\/10.1016\/j.ygyno.2013.02.029\n                      \n                    .","journal-title":"Gynecol Oncol"},{"issue":"4","key":"626_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jocn.2013.05.027","volume":"21","author":"IY Kim","year":"2014","unstructured":"Kim IY, Yun SJ, Lee JS, Jung S, Jung TY, Moon KS, et al. Brain metastasis from extramammary Paget\u2019s disease of the scrotum. J Clin Neurosci. 2014;21(4):694\u20136. \n                      https:\/\/doi.org\/10.1016\/j.jocn.2013.05.027\n                      \n                    .","journal-title":"J Clin Neurosci"},{"issue":"1","key":"626_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ygyno.2011.03.033","volume":"122","author":"IS Jones","year":"2011","unstructured":"Jones IS, Crandon A, Sanday K. Paget\u2019s disease of the vulva: diagnosis and follow-up key to management; a retrospective study of 50 cases from Queensland. Gynecol Oncol. 2011;122(1):42\u20134. \n                      https:\/\/doi.org\/10.1016\/j.ygyno.2011.03.033\n                      \n                    .","journal-title":"Gynecol Oncol"},{"issue":"1","key":"626_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/gyno.1997.4735","volume":"66","author":"F Cappuccini","year":"1997","unstructured":"Cappuccini F, Tewari K, Rogers LW, DiSaia PJ. Extramammary Paget\u2019s disease of the vulva: metastases to the bone marrow in the absence of an underlying adenocarcinoma--case report and literature review. Gynecol Oncol. 1997;66(1):146\u201350. \n                      https:\/\/doi.org\/10.1006\/gyno.1997.4735\n                      \n                    .","journal-title":"Gynecol Oncol"},{"issue":"6","key":"626_CR14","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00432-016-2151-2","volume":"142","author":"T Ito","year":"2016","unstructured":"Ito T, Uchi H, Nakahara T, Tsuji G, Oda Y, Hagihara A, et al. Cutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan. J Cancer Res Clin Oncol. 2016;142(6):1387\u201394. \n                      https:\/\/doi.org\/10.1007\/s00432-016-2151-2\n                      \n                    .","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"626_CR15","doi-asserted-by":"publisher","first-page":"205846011770044","DOI":"10.1177\/2058460117700449.","volume":"6","author":"M Kouzmina","year":"2017","unstructured":"Kouzmina M, Koljonen V, Leikola J, Bohling T, Lantto E. Frequency and locations of systemic metastases in Merkel cell carcinoma by imaging. Acta Radiol Open. 2017;6(3):2058460117700449. \n                      https:\/\/doi.org\/10.1177\/2058460117700449.","journal-title":"Acta Radiol Open"},{"issue":"11","key":"626_CR16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/ddg.12197","volume":"11","author":"Katharina C. K\u00e4hler","year":"2013","unstructured":"Kahler KC, Egberts F, Gutzmer R. Palliative treatment of skin metastases in dermato-oncology. J Dtsch Dermatol Ges. 2013;11(11):1041\u20135; quiz 6. \n                      https:\/\/doi.org\/10.1111\/ddg.12197\n                      \n                    .","journal-title":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"1","key":"626_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/ajd.12205","volume":"56","author":"C Gaulin","year":"2015","unstructured":"Gaulin C, Sebaratnam DF, Fernandez-Penas P. Quality of life in non-melanoma skin cancer. Australas J Dermatol. 2015;56(1):70\u20136. \n                      https:\/\/doi.org\/10.1111\/ajd.12205\n                      \n                    .","journal-title":"Australas J Dermatol"},{"issue":"4","key":"626_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5604\/01.3001.0012.2904","volume":"90","author":"J Wordliczek","year":"2018","unstructured":"\u2022 Wordliczek J, Kotlinska-Lemieszek A, Leppert W, Woron J, Dobrogowski J, Krajnik M, et al. Pharmacotherapy of pain in cancer patients - recommendations of the Polish Association for the Study of Pain, Polish Society of Palliative Medicine, Polish Society of Oncology, Polish Society of Family Medicine, Polish Society of Anaesthesiology and Intensive Therapy and Association of Polish Surgeons. Pol Przegl Chir. 2018;90(4):55\u201384. \n                      https:\/\/doi.org\/10.5604\/01.3001.0012.2904\n                      \n                     A recent article on pharmacotherapy for pain in cancer patients.","journal-title":"Pol Przegl Chir"},{"issue":"3","key":"626_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1053\/j.seminoncol.2011.03.016","volume":"38","author":"WY Cheung","year":"2011","unstructured":"Cheung WY, Zimmermann C. Pharmacologic management of cancer-related pain, dyspnea, and nausea. Semin Oncol. 2011;38(3):450\u20139. \n                      https:\/\/doi.org\/10.1053\/j.seminoncol.2011.03.016\n                      \n                    .","journal-title":"Semin Oncol"},{"issue":"1","key":"626_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0305-7372(98)90072-X","volume":"24","author":"C Ripamonti","year":"1998","unstructured":"Ripamonti C, Fulfaro F, Bruera E. Dyspnoea in patients with advanced cancer: incidence, causes and treatments. Cancer Treat Rev. 1998;24(1):69\u201380.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"626_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/sj.bjc.6605578","volume":"102","author":"M Pressoir","year":"2010","unstructured":"Pressoir M, Desne S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102(6):966\u201371. \n                      https:\/\/doi.org\/10.1038\/sj.bjc.6605578\n                      \n                    .","journal-title":"Br J Cancer"},{"issue":"1","key":"626_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","volume":"34","author":"SC Teunissen","year":"2007","unstructured":"Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag. 2007;34(1):94\u2013104. \n                      https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.10.015\n                      \n                    .","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"626_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1346-8138.12983","volume":"43","author":"H Goto","year":"2016","unstructured":"Goto H, Omodaka T, Yanagisawa H, Yoshikawa S, Yoshida Y, Yamamoto O, et al. Palliative surgical treatment for cutaneous metastatic tumor is a valid option for improvement of quality of life. J Dermatol. 2016;43(1):95\u20138. \n                      https:\/\/doi.org\/10.1111\/1346-8138.12983\n                      \n                    .","journal-title":"J Dermatol"},{"issue":"10","key":"626_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.clon.2010.07.014","volume":"22","author":"EA Barnes","year":"2010","unstructured":"Barnes EA, Breen D, Culleton S, Zhang L, Kamra J, Tsao M, et al. Palliative radiotherapy for non-melanoma skin cancer. Clin Oncol (R Coll Radiol). 2010;22(10):844\u20139. \n                      https:\/\/doi.org\/10.1016\/j.clon.2010.07.014\n                      \n                    .","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"626_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijscr.2011.10.016","volume":"3","author":"J Hachisuka","year":"2012","unstructured":"Hachisuka J, Doi K, Furue M. Combination cryosurgery with hyperthermia in the management of skin metastasis from breast cancer: a case report. Int J Surg Case Rep. 2012;3(2):68\u20139. \n                      https:\/\/doi.org\/10.1016\/j.ijscr.2011.10.016\n                      \n                    .","journal-title":"Int J Surg Case Rep"},{"issue":"2","key":"626_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/1097-0142(19830115)51:2<226::AID-CNCR2820510210>3.0.CO;2-3","volume":"51","author":"CR Johanson","year":"1983","unstructured":"Johanson CR, Harwood AR, Cummings BJ, Quirt I. 0-7-21 radiotherapy in nodular melanoma. Cancer. 1983;51(2):226\u201332.","journal-title":"Cancer"},{"issue":"5","key":"626_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0738-081X(02)00265-1","volume":"20","author":"R Dawber","year":"2002","unstructured":"Dawber R. Cryosurgery: unapproved uses, dosages, or indications. Clin Dermatol. 2002;20(5):563\u201370.","journal-title":"Clin Dermatol"},{"issue":"9","key":"626_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1346-8138.2010.00898.x","volume":"37","author":"H Uno","year":"2010","unstructured":"Uno H, Sasaki M, Osamura K, Ohtoshi S, Nakada T, Iijima M. Angiosarcoma (Stewart-Treves syndrome): palliative role of Mohs\u2019 ointment. J Dermatol. 2010;37(9):852\u20133. \n                      https:\/\/doi.org\/10.1111\/j.1346-8138.2010.00898.x\n                      \n                    .","journal-title":"J Dermatol"},{"issue":"12","key":"626_CR29","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1111\/1346-8138.14030","volume":"44","author":"C Omigawa","year":"2017","unstructured":"Omigawa C, Hashimoto T, Hanafusa T, Namiki T, Igawa K, Yokozeki H. Modified method for applying Mohs\u2019 paste. J Dermatol. 2017;44(12):e353\u2013e4. \n                      https:\/\/doi.org\/10.1111\/1346-8138.14030\n                      \n                    .","journal-title":"J Dermatol"},{"issue":"4","key":"626_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/1346-8138.12767","volume":"42","author":"N Nakai","year":"2015","unstructured":"Nakai N, Okuzawa Y, Katoh N. Clinical usefulness of Mohs\u2019 chemosurgery for palliative purposes in patients with cutaneous squamous cell carcinoma with risk factors or without indication for surgery: three case reports. J Dermatol. 2015;42(4):405\u20137. \n                      https:\/\/doi.org\/10.1111\/1346-8138.12767\n                      \n                    .","journal-title":"J Dermatol"},{"issue":"4","key":"626_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ddg.12583","volume":"13","author":"A Kreuter","year":"2015","unstructured":"Kreuter A, van Eijk T, Lehmann P, Fischer M, Horn T, Assaf C, et al. Electrochemotherapy in advanced skin tumors and cutaneous metastases - a retrospective multicenter analysis. J Dtsch Dermatol Ges. 2015;13(4):308\u201315. \n                      https:\/\/doi.org\/10.1111\/ddg.12583\n                      \n                    .","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"626_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jpainsymman.2009.11.319","volume":"39","author":"CM Costa Santos da","year":"2010","unstructured":"da Costa Santos CM, de Mattos Pimenta CA, Nobre MR. A systematic review of topical treatments to control the odor of malignant fungating wounds. J Pain Symptom Manag. 2010;39(6):1065\u201376. \n                      https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.11.319\n                      \n                    .","journal-title":"J Pain Symptom Manag"},{"issue":"11","key":"626_CR33","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/jamadermatol.2014.895","volume":"150","author":"G Yosipovitch","year":"2014","unstructured":"Yosipovitch G, Mills KC, Nattkemper LA, Feneran A, Tey HL, Lowenthal BM, et al. Association of pain and itch with depth of invasion and inflammatory cell constitution in skin cancer: results of a large clinicopathologic study. JAMA Dermatol. 2014;150(11):1160\u20136. \n                      https:\/\/doi.org\/10.1001\/jamadermatol.2014.895\n                      \n                    .","journal-title":"JAMA Dermatol"},{"issue":"3","key":"626_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/082585979000600303","volume":"6","author":"V Ventafridda","year":"1990","unstructured":"Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients\u2019 last days of life. J Palliat Care. 1990;6(3):7\u201311.","journal-title":"J Palliat Care"},{"issue":"2","key":"626_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/spc.0000000000000043","volume":"8","author":"N Gough","year":"2014","unstructured":"Gough N, Miah AB, Linch M. Nonsurgical oncological management of cancer pain. Curr Opin Support Palliat Care. 2014;8(2):102\u201311. \n                      https:\/\/doi.org\/10.1097\/spc.0000000000000043\n                      \n                    .","journal-title":"Curr Opin Support Palliat Care"},{"issue":"3","key":"626_CR36","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1016\/j.ijrobp.2012.05.028","volume":"84","author":"L Zeng","year":"2012","unstructured":"Zeng L, Chow E, Bedard G, Zhang L, Fairchild A, Vassiliou V, et al. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys. 2012;84(3):e337\u201342. \n                      https:\/\/doi.org\/10.1016\/j.ijrobp.2012.05.028\n                      \n                    .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"626_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/annonc\/mdm442","volume":"19","author":"M Aapro","year":"2008","unstructured":"Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol. 2008;19(3):420\u201332. \n                      https:\/\/doi.org\/10.1093\/annonc\/mdm442\n                      \n                    .","journal-title":"Ann Oncol"},{"issue":"4","key":"626_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0885-3924(96)00327-2","volume":"13","author":"C Ripamonti","year":"1997","unstructured":"Ripamonti C, Bruera E. Dyspnea: pathophysiology and assessment. J Pain Symptom Manag. 1997;13(4):220\u201332.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"626_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/jpm.2012.0364","volume":"16","author":"D Hui","year":"2013","unstructured":"Hui D, Morgado M, Vidal M, Withers L, Nguyen Q, Chisholm G, et al. Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. J Palliat Med. 2013;16(3):274\u201380. \n                      https:\/\/doi.org\/10.1089\/jpm.2012.0364\n                      \n                    .","journal-title":"J Palliat Med"},{"issue":"4","key":"626_CR40","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/cam4.419","volume":"4","author":"F Guirimand","year":"2015","unstructured":"Guirimand F, Sahut d'izarn M, Laporte L, Francillard M, Richard JF, Aegerter P. Sequential occurrence of dyspnea at the end of life in palliative care, according to the underlying cancer. Cancer Med. 2015;4(4):532\u20139. \n                      https:\/\/doi.org\/10.1002\/cam4.419\n                      \n                    .","journal-title":"Cancer Med"},{"issue":"4","key":"626_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jpainsymman.2012.10.284","volume":"46","author":"D Hui","year":"2013","unstructured":"Hui D, Morgado M, Chisholm G, Withers L, Nguyen Q, Finch C, et al. High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manag. 2013;46(4):463\u201373. \n                      https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.10.284\n                      \n                    .","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"626_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1164\/ajrccm\/136.1.58","volume":"136","author":"RM Schwartzstein","year":"1987","unstructured":"Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987;136(1):58\u201361. \n                      https:\/\/doi.org\/10.1164\/ajrccm\/136.1.58\n                      \n                    .","journal-title":"Am Rev Respir Dis"},{"issue":"13\u201314","key":"626_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10354-017-0600-4","volume":"168","author":"M Strieder","year":"2018","unstructured":"Strieder M, Pecherstorfer M, Kreye G. Symptomatic treatment of dyspnea in advanced cancer patients: a narrative review of the current literature. Wien Med Wochenschr. 2018;168(13\u201314):333\u201343. \n                      https:\/\/doi.org\/10.1007\/s10354-017-0600-4\n                      \n                    .","journal-title":"Wien Med Wochenschr"},{"issue":"4","key":"626_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/15360288.2015.1082005","volume":"29","author":"A Vargas-Bermudez","year":"2015","unstructured":"Vargas-Bermudez A, Cardenal F, Porta-Sales J. Opioids for the management of dyspnea in cancer patients: evidence of the last 15 years--a systematic review. J Pain Palliat Care Pharmacother. 2015;29(4):341\u201352. \n                      https:\/\/doi.org\/10.3109\/15360288.2015.1082005\n                      \n                    .","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"5","key":"626_CR45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jpainsymman.2012.05.004","volume":"45","author":"P Gomutbutra","year":"2013","unstructured":"Gomutbutra P, O'Riordan DL, Pantilat SZ. Management of moderate-to-severe dyspnea in hospitalized patients receiving palliative care. J Pain Symptom Manag. 2013;45(5):885\u201391. \n                      https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.05.004\n                      \n                    .","journal-title":"J Pain Symptom Manag"},{"issue":"25","key":"626_CR46","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1200\/jco.2012.44.4661","volume":"31","author":"S Yennurajalingam","year":"2013","unstructured":"Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013;31(25):3076\u201382. \n                      https:\/\/doi.org\/10.1200\/jco.2012.44.4661\n                      \n                    .","journal-title":"J Clin Oncol"},{"issue":"1","key":"626_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11\u201348. \n                      https:\/\/doi.org\/10.1016\/j.clnu.2016.07.015\n                      \n                    .","journal-title":"Clin Nutr"},{"issue":"4","key":"626_CR48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","volume":"69","author":"WD Dewys","year":"1980","unstructured":"Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69(4):491\u20137.","journal-title":"Am J Med"},{"key":"626_CR49","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.14694\/EdBook_AM.2015.35.e229","volume":"35","author":"E Fabbro Del","year":"2015","unstructured":"Del Fabbro E. Current and future care of patients with the cancer anorexia-cachexia syndrome. Am Soc Clin Oncol Educ Book. 2015;35:e229\u201337. \n                      https:\/\/doi.org\/10.14694\/EdBook_AM.2015.35.e229\n                      \n                    .","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"626_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3322\/canjclin.52.2.72","volume":"52","author":"A Inui","year":"2002","unstructured":"Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin. 2002;52(2):72\u201391.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"626_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nut.2009.04.013","volume":"26","author":"GA Wie","year":"2010","unstructured":"Wie GA, Cho YA, Kim SY, Kim SM, Bae JM, Joung H. Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the National Cancer Center in Korea. Nutrition. 2010;26(3):263\u20138. \n                      https:\/\/doi.org\/10.1016\/j.nut.2009.04.013\n                      \n                    .","journal-title":"Nutrition"},{"issue":"8","key":"626_CR52","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.biopha.2013.08.005","volume":"67","author":"A Nicolini","year":"2013","unstructured":"Nicolini A, Ferrari P, Masoni MC, Fini M, Pagani S, Giampietro O, et al. Malnutrition, anorexia and cachexia in cancer patients: a mini-review on pathogenesis and treatment. Biomed Pharmacother. 2013;67(8):807\u201317. \n                      https:\/\/doi.org\/10.1016\/j.biopha.2013.08.005\n                      \n                    .","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"626_CR53","first-page":"154","volume":"44","author":"Y Muliawati","year":"2012","unstructured":"Muliawati Y, Haroen H, Rotty LW. Cancer anorexia - cachexia syndrome. Acta Med Indones. 2012;44(2):154\u201362.","journal-title":"Acta Med Indones"},{"issue":"33","key":"626_CR54","doi-asserted-by":"publisher","first-page":"8500","DOI":"10.1200\/jco.2005.01.8010","volume":"23","author":"T Yavuzsen","year":"2005","unstructured":"Yavuzsen T, Davis MP, Walsh D, LeGrand S, Lagman R. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005;23(33):8500\u201311. \n                      https:\/\/doi.org\/10.1200\/jco.2005.01.8010\n                      \n                    .","journal-title":"J Clin Oncol"},{"issue":"3","key":"626_CR55","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0885-3924(03)00287-2","volume":"26","author":"T Morita","year":"2003","unstructured":"Morita T, Tei Y, Inoue S. Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: prevalence and identification of research focus. J Pain Symptom Manag. 2003;26(3):827\u201334.","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"626_CR56","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1089\/jpm.2005.8.1042","volume":"8","author":"WM Plonk Jr","year":"2005","unstructured":"Plonk WM Jr, Arnold RM. Terminal care: the last weeks of life. J Palliat Med. 2005;8(5):1042\u201354. \n                      https:\/\/doi.org\/10.1089\/jpm.2005.8.1042\n                      \n                    .","journal-title":"J Palliat Med"},{"issue":"9","key":"626_CR57","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1200\/jco.2001.19.9.2542","volume":"19","author":"N Cherny","year":"2001","unstructured":"Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19(9):2542\u201354. \n                      https:\/\/doi.org\/10.1200\/jco.2001.19.9.2542\n                      \n                    .","journal-title":"J Clin Oncol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-019-0626-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-019-0626-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-019-0626-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:12:30Z","timestamp":1585181550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-019-0626-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1007\/s11864-019-0626-5","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"27 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Hiroyuki Goto, Yoshio Kiyohara, Masahisa Shindo, and Osamu Yamamoto declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"34"}}